T2 Biosystems
In Brief This Week: ADLM, Labcorp, Foresight Diagnostics, T2 Biosystems, More
News items for the week of Oct. 7, 2024.
Beckman Coulter, T2 Biosystems, Others Gain 510(k) Clearances in September
The US Food and Drug Administration granted marketing clearances for multiple infectious disease tests and a blood culture sample preparation system, among other devices.
T2 Biosystems Preliminary Q3 Revenues up 33 Percent; Reaches Deal With Cardinal Health
The firm executed contracts for 11 T2Dx instruments in the quarter and saw its sepsis test panel revenue increase 42 percent.
T2 Biosystems Pathogen Detection Patent Upheld in Europe
French diagnostics maker BioMérieux and other undisclosed firms had filed an opposition to the patent in May 2023.
T2 Biosystems Candida Assay Cleared by FDA for Pediatric Use
The Lexington, Massachusetts-based diagnostics maker said the clearance enables it to sell the test to more than 200 children's hospitals.
May 15, 2024
T2 Biosystems to Raise $8M in Private Placement
Nov 27, 2023